INVION

ANNUAL GENERAL MEETING

NEW MARKET OPPORTUNITIES EXPANDED TERRITORIES AND NEW DISEASE AREAS

Invion’s exclusive territories gives it access to markets with >2.8 billion people

Atherosclerosis

Disease where plaque builds up inside arteries.

Global treatment market is forecast to hit US$56.6 billion by 20271, and Asia Pacific is the fastest growing region2.

Atherosclerosis is a major contributor to cardiovascular diseases – the largest cause of death worldwide3.

Infectious Diseases.

Global market worth US$166.5bn by 2026 and growing at ~8% CAGR4.

Environmental and climate change make infectious diseases more challenging to control5. Global pandemic has highlighted need for new treatments

PATHWAY TO CLINICAL TRIALS

Invion is building on early successes by identifying target cancer indications with our partner institutions whilst making pre-clinical preparations with a view to initiating clinical trials in more than one indication in 2022

IVX AGM-Presentation.PDF

INV043 SHOWN TO COMPLETELY REGRESS TNBC TUMOURS AND TRIGGER PROTECTIVE IMMUNITY

Highlights:

• Latest PoC pilot studies show complete regression of triple negative breast cancer (TNBC) in vivo following INV043 treatment

• TNBC is a hard-to-treat cancer that is resistant to most chemotherapies. It represents one of many cancer types where a strong clinical need exists for alternatives to current standard of care

• Tumour mass was undetectable two weeks after initial treatment and no scarring was evident • There was no recurrence of disease and re-challenge with TNBC implant could not reestablish new tumours, suggesting the development of protective immunity

• Additional PoC tests being carried out by Hudson Institute

PDT treatment using INV043 resulted in complete tumour regression with no recurrence of disease.

Complete-Regression-of-TNBC-Tumours-and-Protective-Immunity.PDF

Life sciences company Invision Group IVX rapidly advancing its next-generation photodynamic therapy INV043 for treating numerous cancers.

The drug is under development in collaboration with the world-leading Hudson Institute of Medical Research in Victoria.

Photodynamic therapy is an emerging technology used in the treatment of cancer and some other non-malignant conditions.

Essentially, it works by using a drug that is activated by light to kill cancer cells.

Light is used in the form of lasers or LEDs.

It is a localised therapy, and mostly used to treat specific parts of the body.

These drug can use to kill cancer cells without the side effects.

Raise $4.5mil at $0.014c in June, enough for fund for first clinical trail inv043 end of 2021.

Interview with CEO Thian Chew

https://youtu.be/Z4IbrCxXCJE?list=TLGG1FncrEL0Uo4xMzA5MjAyMQ